February 27, 2020

February 27, 2020

Subscribe to Latest Legal News and Analysis

February 26, 2020

Subscribe to Latest Legal News and Analysis

February 25, 2020

Subscribe to Latest Legal News and Analysis

February 24, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
27
Feb
Ethical Veganism And The Broadening Range Of Philosophical Beliefs Protected By UK Discrimination Laws McDermott Will & Emery
27
Feb
FDA Data Shows an Increase in Food Facility Violations for Failing to Develop a Foreign Supplier Verification Program Keller and Heckman LLP
27
Feb
Antitrust Byte: FDA and FTC Join Forces to Promote Biosimilars Epstein Becker & Green, P.C.
26
Feb
FDA Issues More Guidance On Intentional Adulteration Of Food Rule Barnes & Thornburg LLP
26
Feb
Comments on Draft Risk Evaluation for Trichloroethylene Due April 27 Bergeson & Campbell, P.C.
26
Feb
New Jersey Labor Department Issues Companies Stop-Work Orders for Wage Violations Jackson Lewis P.C.
26
Feb
California Federal Judge Certifies Class in “Pure” Honey Labeling Suit Keller and Heckman LLP
25
Feb
Necessity Is The Mother Of Single Reference Anticipation By Inherency Foley & Lardner LLP
25
Feb
CMS Proposes Significant Changes to Medicare Advantage & Part D for 2021 and Beyond, Part 2: CMS Proposes to Codify Supplemental Benefit Rules and Update MLR Mintz
25
Feb
JUUL’s Efforts to Recruit Influencers Stark & Stark
24
Feb
ECHA Urges Companies to Provide More Data on Nanoforms Bergeson & Campbell, P.C.
24
Feb
Anticompetitive Patent-Listing Decision May Clear Patent Thicket for Generic Pharma Industry Schiff Hardin LLP
24
Feb
Is “Cannabis User” the Next Protected Class in California? Jackson Lewis P.C.
24
Feb
340B Ceiling Price Transparency – HRSA Now Requiring Pharmaceutical Manufacturers to Issue Refunds to Covered Entities for Overcharges Mintz
24
Feb
2019 FDA Precision Medicine Approvals: Progress At FDA Foley & Lardner LLP
24
Feb
Federal Judge Dismisses Amended Complaint Over Dog Food Labeled as “Natural” Containing Trace Levels of Glyphosate Weed Killer Keller and Heckman LLP
21
Feb
EPA Releases Proposed Supplemental SNUR on LCPFAC Chemical Substances Bergeson & Campbell, P.C.
21
Feb
FDA Reopens Comment Period on General Principles for Food Standards Modernization Keller and Heckman LLP
21
Feb
BRAG Biobased Products Blog: February 21, 2020 Bergeson & Campbell, P.C.
21
Feb
California Update: New QR Code Certificate Requirements, Uptick in Enforcement Actions, and the Future of California’s Cannabis Regulators Sheppard, Mullin, Richter & Hampton LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS